The Role of the Guanosine Nucleotide-Binding Protein in the Corpus Luteum

Overview

Journal Animals (Basel)

Date 2021 Jun 2

PMID 34073800

Authors

Dody Houston Billhaq

Seunghyung Lee

Affiliations

Soon will be listed here.

Abstract

The corpus luteum is a temporary endocrine gland in the ovary. In the ovarian cycle, repeated patterns of specific cellular proliferation, differentiation, and transformation occur that accompany the formation and regression of the corpus luteum. Molecular mechanism events in the ovarian microenvironment, such as angiogenesis and apoptosis, are complex. Recently, we focused on the role of RAS protein in the ovarian corpus luteum. RAS protein plays a vital role in the modulation of cell survival, proliferation, and differentiation by molecular pathway signaling. Additionally, reproductive hormones regulate RAS activity in the cellular physiological function of ovarian follicles during pre-ovulatory maturation and ovulation. Thus, we have reviewed the role of RAS protein related to the biological events of the corpus luteum in the ovary.

References

Niswender G, Juengel J, Silva P, Rollyson M, McIntush E . Mechanisms controlling the function and life span of the corpus luteum. Physiol Rev. 2000; 80(1):1-29. DOI: 10.1152/physrev.2000.80.1.1. View

Fan H, Richards J . Minireview: physiological and pathological actions of RAS in the ovary. Mol Endocrinol. 2009; 24(2):286-98. PMC: 2817603. DOI: 10.1210/me.2009-0251. View

Kliem H, Berisha B, Meyer H, Schams D . Regulatory changes of apoptotic factors in the bovine corpus luteum after induced luteolysis. Mol Reprod Dev. 2008; 76(3):220-30. DOI: 10.1002/mrd.20946. View

Richards J, Pangas S . The ovary: basic biology and clinical implications. J Clin Invest. 2010; 120(4):963-72. PMC: 2846061. DOI: 10.1172/JCI41350. View

Krsmanovic L, Hu L, Leung P, Feng H, Catt K . The hypothalamic GnRH pulse generator: multiple regulatory mechanisms. Trends Endocrinol Metab. 2009; 20(8):402-8. PMC: 2769988. DOI: 10.1016/j.tem.2009.05.002. View

Hunzicker-Dunn M, Lopez-Biladeau B, Law N, Fiedler S, Carr D, Maizels E . PKA and GAB2 play central roles in the FSH signaling pathway to PI3K and AKT in ovarian granulosa cells. Proc Natl Acad Sci U S A. 2012; 109(44):E2979-88. PMC: 3497822. DOI: 10.1073/pnas.1205661109. View

Pylayeva-Gupta Y, Grabocka E, Bar-Sagi D . RAS oncogenes: weaving a tumorigenic web. Nat Rev Cancer. 2011; 11(11):761-74. PMC: 3632399. DOI: 10.1038/nrc3106. View

Lalioti M . Impact of follicle stimulating hormone receptor variants in fertility. Curr Opin Obstet Gynecol. 2011; 23(3):158-67. DOI: 10.1097/GCO.0b013e3283455288. View

Chavan T, Muratcioglu S, Marszalek R, Jang H, Keskin O, Gursoy A . Plasma membrane regulates Ras signaling networks. Cell Logist. 2016; 5(4):e1136374. PMC: 4820813. DOI: 10.1080/21592799.2015.1136374. View

10.

Moura M, Cavaco B, Leite V . RAS proto-oncogene in medullary thyroid carcinoma. Endocr Relat Cancer. 2015; 22(5):R235-52. DOI: 10.1530/ERC-15-0070. View

11.

Ii M, Li H, Adachi Y, Yamamoto H, Ohashi H, Taniguchi H . The efficacy of IGF-I receptor monoclonal antibody against human gastrointestinal carcinomas is independent of k-ras mutation status. Clin Cancer Res. 2011; 17(15):5048-59. DOI: 10.1158/1078-0432.CCR-10-3131. View

12.

Jiang X, Dias J, He X . Structural biology of glycoprotein hormones and their receptors: insights to signaling. Mol Cell Endocrinol. 2013; 382(1):424-451. DOI: 10.1016/j.mce.2013.08.021. View

13.

Yang J, Gong Z, Shen X, Bai S, Bai X, Wei S . FSH receptor binding inhibitor depresses carcinogenesis of ovarian cancer via decreasing levels of K-Ras, c-Myc and FSHR. Anim Biotechnol. 2019; 32(1):84-91. DOI: 10.1080/10495398.2019.1656083. View

14.

Li W, Liang R, Zhou C, Wu M, Lian L, Yuan G . The association between expressions of Ras and CD68 in the angiogenesis of breast cancers. Cancer Cell Int. 2015; 15(1):17. PMC: 4326448. DOI: 10.1186/s12935-015-0169-1. View

15.

Ulloa-Aguirre A, Reiter E, Crepieux P . FSH Receptor Signaling: Complexity of Interactions and Signal Diversity. Endocrinology. 2018; 159(8):3020-3035. DOI: 10.1210/en.2018-00452. View

16.

Neuvians T, Berisha B, Schams D . Vascular endothelial growth factor (VEGF) and fibroblast growth factor (FGF) expression during induced luteolysis in the bovine corpus luteum. Mol Reprod Dev. 2004; 67(4):389-95. DOI: 10.1002/mrd.20032. View

17.

Woods D, Johnson A . Protein kinase C activity mediates LH-induced ErbB/Erk signaling in differentiated hen granulosa cells. Reproduction. 2007; 133(4):733-41. DOI: 10.1530/REP-06-0261. View

18.

Howles C . Role of LH and FSH in ovarian function. Mol Cell Endocrinol. 2000; 161(1-2):25-30. DOI: 10.1016/s0303-7207(99)00219-1. View

19.

Berisha B, Meyer H, Schams D . Effect of prostaglandin F2 alpha on local luteotropic and angiogenic factors during induced functional luteolysis in the bovine corpus luteum. Biol Reprod. 2010; 82(5):940-7. DOI: 10.1095/biolreprod.109.076752. View

20.

Johnson D, Chen Y . Ras family of small GTPases in immunity and inflammation. Curr Opin Pharmacol. 2012; 12(4):458-63. PMC: 3374043. DOI: 10.1016/j.coph.2012.02.003. View